Precision BioSciences, Inc.
DTIL
$7.43
$0.131.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 45.06M | 45.07M | 34.26M | 698.00K | 1.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 45.06M | 45.07M | 34.26M | 698.00K | 1.26M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 45.06M | 45.07M | 34.26M | 698.00K | 1.26M |
| SG&A Expenses | 28.81M | 31.17M | 32.92M | 32.89M | 34.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 81.45M | 84.18M | 86.41M | 90.20M | 91.37M |
| Operating Income | -36.40M | -39.11M | -52.15M | -89.50M | -90.11M |
| Income Before Tax | -53.62M | -44.49M | -46.61M | -83.60M | -78.26M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -53.62 | -44.49 | -46.61 | -83.60 | -78.26 |
| Earnings from Discontinued Operations | 885.00K | 885.00K | 885.00K | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -52.73M | -43.60M | -45.72M | -83.60M | -78.26M |
| EBIT | -36.40M | -39.11M | -52.15M | -89.50M | -90.11M |
| EBITDA | -35.15M | -37.74M | -50.68M | -87.93M | -88.17M |
| EPS Basic | -2.80 | -3.66 | -5.13 | -8.40 | -8.81 |
| Normalized Basic EPS | -1.68 | -2.09 | -3.08 | -5.05 | -5.35 |
| EPS Diluted | -2.81 | -3.67 | -5.14 | -8.41 | -8.82 |
| Normalized Diluted EPS | -1.69 | -2.09 | -3.09 | -5.05 | -5.35 |
| Average Basic Shares Outstanding | 81.36M | 66.55M | 51.21M | 40.16M | 35.63M |
| Average Diluted Shares Outstanding | 81.48M | 66.67M | 51.33M | 40.16M | 35.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |